These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34002934)

  • 1. Elevated serum pentosidine is independently associated with the high prevalence of sarcopenia in Chinese middle-aged and elderly men with type 2 diabetes mellitus.
    Zhang X; Liu J; Zhang Q; Lu A; Du Y; Ye X
    J Diabetes Investig; 2021 Nov; 12(11):2054-2061. PubMed ID: 34002934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Serum Pentosidine and Decreased Serum IGF-I Levels are Associated with Loss of Muscle Mass in Postmenopausal Women with Type 2 Diabetes Mellitus.
    Tanaka K; Kanazawa I; Sugimoto T
    Exp Clin Endocrinol Diabetes; 2016 Mar; 124(3):163-6. PubMed ID: 26575120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased serum musclin concentration is independently associated with the high prevalence of sarcopenia in Chinese middle-elderly patients with type 2 diabetes mellitus.
    Fu L; Zhang Q; Liu J; Yuan X; Ye X
    J Diabetes Investig; 2023 Dec; 14(12):1412-1418. PubMed ID: 37737466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary pentosidine level is associated with grip strength and gait speed in community-dwelling adults: a cross-sectional study.
    Moriwaki K; Matsumoto H; Tanimura C; Osaki M; Nagashima H; Hagino H
    BMC Musculoskelet Disord; 2021 Apr; 22(1):392. PubMed ID: 33902533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentosidine concentration is associated with degenerative lumbar scoliosis in older women: preliminary results.
    Eguchi Y; Toyoguchi T; Inage K; Fujimoto K; Orita S; Yamauchi K; Suzuki M; Kanamoto H; Abe K; Norimoto M; Umimura T; Koda M; Furuya T; Aoki Y; Takahashi K; Ohtori S
    Eur Spine J; 2018 Mar; 27(3):597-606. PubMed ID: 29127513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High serum pentosidine but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glycaemic control.
    Neumann T; Lodes S; Kästner B; Franke S; Kiehntopf M; Lehmann T; Müller UA; Wolf G; Sämann A
    Osteoporos Int; 2014 May; 25(5):1527-33. PubMed ID: 24599273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopenia and sarcopenic obesity among men aged 80 years and older in Beijing: prevalence and its association with functional performance.
    Meng P; Hu YX; Fan L; Zhang Y; Zhang MX; Sun J; Liu Y; Li M; Yang Y; Wang LH; Zhang Y; Gao W; Han XQ; Chen LK
    Geriatr Gerontol Int; 2014 Feb; 14 Suppl 1():29-35. PubMed ID: 24450558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between body fat and sarcopenia in older adults with type 2 diabetes mellitus: A cross-sectional study.
    Sun L; Fu J; Mu Z; Duan X; Chan P; Xiu S
    Front Endocrinol (Lausanne); 2023; 14():1094075. PubMed ID: 36777353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy.
    Ghanem AA; Elewa A; Arafa LF
    Eur J Ophthalmol; 2011; 21(1):48-54. PubMed ID: 20544678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes.
    Yoshida N; Okumura K; Aso Y
    Metabolism; 2005 Mar; 54(3):345-50. PubMed ID: 15736112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is the serum concentration of pentosidine a predictor of cardiovascular events in patients with type 2 diabetes and kidney disease?].
    Busch M; Franke S; Stein G; Wolf G;
    Dtsch Med Wochenschr; 2007 Sep; 132(36):1810-4. PubMed ID: 17726651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High serum concentrations of pentosidine, an advanced glycation end product, are associated with low normal value of ankle-brachial index in apparently healthy men.
    Takahashi R; Imamura A; Yoshikane M; Suzuki M; Murakami R; Cheng XW; Numaguchi Y; Ikeda N; Murohara T; Okumura K
    Metabolism; 2011 May; 60(5):649-54. PubMed ID: 20719345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients.
    Kerkeni M; Saïdi A; Bouzidi H; Letaief A; Ben Yahia S; Hammami M
    Diab Vasc Dis Res; 2013 May; 10(3):239-45. PubMed ID: 23091285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes and Risk Factors of Skeletal Muscle Mass and Strength in Patients with Type 2 Diabetes over 60 Years Old: A Cross-Sectional Study from China.
    Hou L; Liu Y; Li X; Huo C; Jia X; Yang J; Lei Y; Xu R; Sun C; Wang X
    J Diabetes Res; 2020; 2020():9815485. PubMed ID: 33381601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between plasma pentosidine concentrations and retinal hemodynamics in patients with type 2 diabetes.
    Sato E; Nagaoka T; Yokota H; Takahashi A; Yoshida A
    Am J Ophthalmol; 2012 May; 153(5):903-909.e1. PubMed ID: 22265156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of accumulated advanced glycation end-products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes.
    Mori H; Kuroda A; Ishizu M; Ohishi M; Takashi Y; Otsuka Y; Taniguchi S; Tamaki M; Kurahashi K; Yoshida S; Endo I; Aihara KI; Funaki M; Akehi Y; Matsuhisa M
    J Diabetes Investig; 2019 Sep; 10(5):1332-1340. PubMed ID: 30677242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum advanced glycation endproducts are associated with left ventricular dysfunction in normal glucose metabolism but not in type 2 diabetes: The Hoorn Study.
    Linssen PB; Henry RM; Schalkwijk CG; Dekker JM; Nijpels G; Brunner-La Rocca HP; Stehouwer CD
    Diab Vasc Dis Res; 2016 Jul; 13(4):278-85. PubMed ID: 27190078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia prevalence using handgrip strength or chair stand performance in adults living with type 2 diabetes mellitus.
    Belfield AE; Wilkinson TJ; Henson J; Sargeant JA; Breen L; Hall AP; Davies MJ; Yates T
    Age Ageing; 2024 May; 53(5):. PubMed ID: 38706394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of metformin and pioglitazone on serum pentosidine levels in type 2 diabetes mellitus.
    Kanazawa I; Yamamoto M; Yamaguchi T; Sugimoto T
    Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):362-5. PubMed ID: 21472665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High serum level of pentosidine, an advanced glycation end product (AGE), is a risk factor of patients with heart failure.
    Koyama Y; Takeishi Y; Arimoto T; Niizeki T; Shishido T; Takahashi H; Nozaki N; Hirono O; Tsunoda Y; Nitobe J; Watanabe T; Kubota I
    J Card Fail; 2007 Apr; 13(3):199-206. PubMed ID: 17448417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.